Bladder cancer

Select a topic (

) of interest

• Management of M0 muscle-invasive bladder cancer beyond radical cystectomy
• Variant histology = radical cystectomy, right?
• UPDATED --- New hope for patients progressing after first-line treatment for mUCa
• UPDATED --- It’s getting personalised: first-line therapy of synchronous or metachronous mUCa
• Immunotherapy: handling AEs and special populations
• Challenges in high-risk NMIBC
• Low- and intermediate-risk NMIBC: surveillance or intravesical therapy?

Join the PinPoint Case Platform

• Receive essential clinical cases with targeted feedback
• Compare your decisions with peers and experts
• Get accredited CME courses for free

Free subscription

Up-to-date in Bladder cancer?

• See where you are in 5 minutes
• Compare with colleagues from all over the world
• Get personalised feedback to improve your knowledge

Do the QuickScan